Aigen Sciences

Seoul, South Korea · Founded 2021 · Privately Held (backing)

Operator of an artificial intelligence (AI) based new drug development platform intended to discover high-potency drugs. Aigen Sciences is based in Seoul, South Korea and was founded in 2021. It has raised $12 million.

Last price · $/share
—
Implied valuation
—
Total raised
$12.0M
Last round
—

Who backs Aigen Sciences?

11 investors
InvestorType
Partners InvestmentVenture capital
Premier PartnersPE / buyout
Bluepoint PartnersVenture capital
K2 Investment PartnersVenture capital
Hyosung VenturesVenture capital
QUAD Investment ManagementHedge fund
Bluepoint—
KU Startup—
Korea University Holdings—
Medytox—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aigen Sciences investors

11 investors are on record for Aigen Sciences, including Partners Investment, Premier Partners, Bluepoint Partners and K2 Investment Partners. By type, the record holds 4 venture capital firms, 1 hedge fund and 1 private equity firm.

Free account
More of Aigen Sciences with a free account
  • ·The complete investor list: 11 names
  • ·Watch Aigen Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Aigen Sciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View